English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Kentucky shows progress in lung cancer incidence and survival according to new report
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Alabama ranks second worst nationally for lung cancer survival rate
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Louisiana ranks low in national lung cancer survival rates according to new report
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

UTHealth Houston integrates arts into medical education for enhanced empathy
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Arkansas struggles with low lung cancer survival rates according to new report
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

American Lung Association urges action on low early diagnosis rates in Georgia
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Tennessee ranks low in national lung cancer rates according to new report
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Guidance offered for holiday eating while on GLP-1 weight loss medication

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes